3.87.33.97
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Oculoplastics-ASOPRS

Teprotumumab may improve ocular surface disease in patients with TED

Ocular surface symptoms are a common complaint for patients with thyroid eye disease (TED). Data from a new study presented at the ASOPRS 52nd Annual Fall Scientific Symposium found that teprotumumab significantly improved ocular surface disease measurements and visual functioning-related quality of life in patients with TED. Researchers analyzed 16...

Read More
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
Videos
19 Sep, 2021

Even after acute thyroid eye disease (TED) symptoms have subsided,...

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-